University research records
Medical University of Varna
7 imported, source-linked research records. All imported publication dates.
All imported publication dates
Back to university profile →7 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Medical University of Varna are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–7 of 7 matching records. Counts update as records arrive.
Finerenone in diabetic kidney disease: Findings from a single-center retrospective observational study
August 28, 2026 · 0 citations · Open access
Open original record →Guideline-Directed Medical Therapy for Diabetic Kidney Disease: Advances in Primary and Secondary Prevention
January 19, 2026 · 3 citations · Open access
Open original record →Diabetes mellitus – a leading risk factor for the development and progression of chronic kidney disease
January 8, 2026 · 0 citations · Open access
Open original record →Impact of empagliflozin on quality-of-life in real-world patients with heart failure: insights from the multinational Emp-Activity study
November 1, 2025 · 2 citations
Open original record →Caloric restriction mimetics as a therapeutic approach to metabolic syndrome
September 1, 2023 · 0 citations · Open access
Open original record →Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction
November 9, 2021 · 53 citations · Open access
Open original record →Assessment Of Renal Function In Patients With Type 2 Diabetes Mellitus And Heart Failure With Preserved Ejection Fraction In Treatment With Empagliflozin
September 10, 2021 · 0 citations · Open access
Open original record →